The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global computational biology market was valued at US$ 3.9 Billion in 2021.
We expect the global computational biology market to exhibit a CAGR of 22.1% during 2022-2027.
The rising demand for computational biology solutions, to reduce the overall time required for drug
discovery and numerous other scientific experiments, is primarily driving the global computational
The sudden outbreak of the COVID-19 has led to the increasing demand for computational biology to
understand the viral pathogenic mechanism and propose novel therapeutic techniques, for identifying
safe and effective remedial solutions to treat the coronavirus infection.
Based on the application, the global computational biology market can be segmented into cellular and
biological simulation, drug discovery and disease modelling, preclinical drug development, clinical trials,
and human body simulation software. Among these, cellular and biological simulation currently holds
the majority of the total market share.
Based on the services, the global computational biology market has been divided into in-house and
contract. Currently, contract exhibits a clear dominance in the market.
Based on the end use, the global computational biology market can be categorized into academics,
pharmaceutical industry, and commercial. Among these, the commercial sector accounts for the largest
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin
America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global computational biology market include Certara, Chemical
Computing Group ULC, Compugen Ltd, Dassault Systèmes, Genedata AG, Insilico Biotechnology AG,
Instem plc, Nimbus Therapeutics LLC, Schrödinger Inc., and Simulations Plus Inc.
Clinical Decision Support Systems (CDSS) Market by Component (Hardware, Software, Services), Product (Integrated CDSS, Standalone CDSS), Type (Therapeutic, Diagnostic), Delivery Mode (On Premise, Cloud Based), Model (Knowledge Based, Non-Knowledge Based), Application (Drug Allergy Alerts, Clinical Guidelines, Drug-Drug Interactions, Clinical Reminders, and Others), and Region 2023-2028
Blockchain in Healthcare Market by Network Type (Private, Public, and Others), Application (Supply Chain Management, Data Exchange and Interoperability, Claims Adjudication and Billing Management, and Others), End Use (Healthcare Providers, Healthcare Payers, Biopharmaceutical & Medical Device Companies, and Others), and Region 2023-2028
Disinfection Robots Market by Product Type (UV-Disinfection Robot, Hydrogen Peroxide Vaporization Robot (HPV), and Others), Technology (Fully Autonomous Disinfection Robots, Semi-Autonomous Disinfection Robots), End User (Hospitals and Clinics, Research Institutes, and Others), and Region 2023-2028
Remote Healthcare Market by Service (Remote Patient Monitoring, Real Time Virtual Health, Tele-ICU), Application (Diagnosis, Cardiology, Obstetrics, Senior Care, and Others), End User (Payer, Provider, Patient, Employer Groups and Government Organizations), and Region 2023-2028
Medication Management Market by Software (Computerized Physician Order Entry System, Clinical Decision Support System, Administration Software, Inventory Management System, Automated Dispensing Systems, Assurance System), Services (Medication Analytics Services, Point-Of-Care Verification Services, Adverse Drug Event (ADE) Surveillance Services), Mode of Delivery (Web-based, Cloud-based, On-premises), End User (Pharmacies, Hospitals and Others) and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at